Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 127

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 127
---
 on August 29, 2025, and the initial 30-day waiting period will expire at 11:59 p.m., Eastern Time, on
September 29, 2025, unless otherwise terminated or extended.

At any time before or after the consummation of the Merger,
notwithstanding the termination or expiration of the waiting period under the HSR Act, the FTC or the DOJ could take such action under the antitrust laws as it deems necessary or desirable in the public interest, including seeking to enjoin the
completion of the Merger, seeking divestiture of substantial assets of the parties, or requiring the parties to license or hold separate assets or terminate existing relationships and contractual rights. At any time before or after the completion of
the Merger, any state could take such action under the antitrust laws as it deems necessary or desirable in the public interest. Such action could include seeking to enjoin the completion of the Merger or seeking divestiture of substantial assets of
the parties. U.S. state attorneys general and private parties may also seek to take legal action under the antitrust laws under certain circumstances. STAAR cannot be certain that a challenge to the Merger will not be made or that, if a challenge is
made, STAAR will prevail.

In addition to clearance under the HSR Act, the consummation of the Merger is also subject to the receipt of
regulatory approvals under China antitrust, Japan antitrust, Turkey antitrust, United Kingdom antitrust, Spain antitrust, Portugal antitrust, Australia antitrust, Kingdom of Saudi Arabia antitrust and Austria antitrust laws, as set forth in greater
detail in “The Merger Agreement—Conditions to the Closing of the Merger.”

Required Vote

The affirmative vote of the holders of a majority of the outstanding shares of STAAR common stock entitled to vote thereon is required for
approval of the Merger Proposal.

Assuming a quorum is present, (1) a failure to be represented by proxy or attend the Special
Meeting, (2) abstentions and (3) “broker non-votes” (if any) will each have the same effect as a vote “AGAINST” the Merger Proposal. Shares of STAAR common stock
represented by properly executed, timely received and unrevoked proxies will be voted in accordance with the instructions indicated thereon. If a STAAR stockholder returns a signed WHITE proxy card without indicating voting preferences on such WHITE
proxy card,